Start Date
November 30, 2001
Primary Completion Date
March 31, 2002
ziv-aflibercept
Memorial Sloan-Kettering Cancer Center, New York
National Cancer Institute (NCI)
NIH
Regeneron Pharmaceuticals
INDUSTRY